Safety and efficacy evaluation of two doses of HFA-propelled beclomethasone dipropionate (QVAR) versus placebo by breath operated and metered dose inhalers in mild to moderate asthmatic children.

Trial Profile

Safety and efficacy evaluation of two doses of HFA-propelled beclomethasone dipropionate (QVAR) versus placebo by breath operated and metered dose inhalers in mild to moderate asthmatic children.

Completed
Phase of Trial: Phase III

Latest Information Update: 25 Aug 2011

At a glance

  • Drugs Beclometasone (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Mar 2008 Additional lead trial centre identified as reported by ClinicalTrials.gov, last updated 31 Mar 2008.
    • 31 Mar 2008 Teva-Pharmaceutical-Industries added as trial sponsor and affiliate as reported by ClinicalTrials.gov.
    • 22 Dec 2007 Status changed from in progress to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top